Cilomilast

N/A

Report date: 2026/03/09 20:02:04

Base Information

Drug NameCilomilast
Drug Alias Name西米司特Cilomilastum西洛司特ArifloAL-38583 +[7] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPhosphodieterase 4 inhibitors
TargetsPhosphodieterase 4
Therapy Area/IndicationsXerophthalmiaConjunctivitis, AllergicPulmonary Disease, Chronic Obstructive
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesGlaxosmithkline Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGlaxosmithkline PlcAlcon
Active IndicationsN/A
Inactive IndicationsXerophthalmiaConjunctivitis, AllergicPulmonary Disease, Chronic Obstructive

Other Information

ATC CodeN/A
Related LinksWikipediaDrugBankKEGG